.png){kind=icon}
Return
Inconsistent Regulators: Evidence from Banking
.png){kind=icon}
OA
AI
DOI：10.1093/qje/qju003.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
We find that regulators can implement identical rules inconsistently due to differences in their institutional design and incentives, and this behavior may adversely impact the effectiveness with which regulation is implemented. We study supervisory decisions of U.S. banking regulators and exploit a legally determined rotation policy that assigns federal and state supervisors to the same bank at exogenously set time intervals. Comparing federal and state regulator supervisory ratings within the same bank, we find that federal regulators are systematically tougher, downgrading supervisory ratings almost twice as frequently as do state supervisors. State regulators counteract these downgrades to some degree by upgrading more frequently. Under federal regulators, banks report worse asset quality, higher regulatory capital ratios, and lower return on assets. Leniency of state regulators relative to their federal counterparts is related to costly outcomes, such as higher failure rates and lower repayment rates of government assistance funds. The discrepancy in regulator behavior is related to different weights given by regulators to local economic conditions and, to some extent, differences in regulatory resources. We find no support for regulator self-interest, which includes revolving doors as a reason for leniency of state regulators.
Keywords:
G21
G28
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
12.7
Papers:
1.2K
Citations:
4.1W
Organization
Cited Papers
ShareSaveSecurity Analysis and Improvement of an Image Encryption Cryptosystem Based on Bit Plane Extraction and Multi Chaos.png)
EntropyOAAI
EntropyIF0
OAAIShareSaveShareSaveGLI3 repressor determines Hedgehog pathway activation and is required for response to SMO antagonist glasdegib in AMLBloodOAAI
BloodIF0
OAAIShareSaveShareSave
View more